Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
Authors:
- Holger BastiansHBHolger Bastians
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 10 (4-5) , 162-181
Abstract
No abstract availableKeywords
This publication has 163 references indexed in Scilit:
- A Microtubule-Independent Role for Centrosomes and Aurora A in Nuclear Envelope BreakdownDevelopmental Cell, 2007
- Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseProceedings of the National Academy of Sciences, 2007
- Genome-wide functional analysis of human cell-cycle regulatorsProceedings of the National Academy of Sciences, 2006
- Mitotic Checkpoint Slippage in Humans Occurs via Cyclin B Destruction in the Presence of an Active CheckpointCurrent Biology, 2006
- Aurora A, mitotic entry, and spindle bipolarityProceedings of the National Academy of Sciences, 2006
- Polo-like kinases and the orchestration of cell divisionNature Reviews Molecular Cell Biology, 2004
- Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidyOncogene, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localizationNature Structural & Molecular Biology, 2002
- Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivoCell, 1995